Status and phase
Conditions
Treatments
About
The main purpose of this study was to assess the safety and tolerability of MSB0011359C. Study consists of dose-escalation part and an expansion part in participants with metastatic or locally advanced solid tumors, for which no standard effective therapy exists or a standard therapy had failed.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Other protocol-defined exclusion criteria could apply.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
114 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal